Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 14, 2020

Total Value ($000): $203,849 (100.0% shares, 0.0% debt)

Holdings (8)

— REVANCE THERAPEUTICS INC 40.0%

Value ($000) $81,613 Shares 3,342,047 Est. Cost $31.50 Unrealized —

— VENUS CONCEPT, INC. 21.3%

Value ($000) $43,338 Shares 12,417,856 Est. Cost $4.17 Unrealized —

— EYEPOINT PHARMACEUTICALS INC 15.6%

Value ($000) $31,851 Shares 41,909,219 Est. Cost $1.64 Unrealized —

AXGN AXOGEN INC 11.0%

Value ($000) $22,453 Shares 2,429,999 Est. Cost $4.01 Unrealized +123.7%

TELA TELA BIO, INC. 8.8%

Value ($000) $18,037 Shares 1,391,768 Est. Cost $12.72 Unrealized +3.3%

MNOV MEDICINOVA INC 2.9%

Value ($000) $5,994 Shares 1,105,941 Est. Cost $2.95 Unrealized +79.8%

— CATALYST BIOSCIENCES INC 0.2%

Value ($000) $462 Shares 78,622 Est. Cost $7.36 Unrealized —

— ENDOLOGIX INC 0.0%

Value ($000) $101 Shares 125,747 Est. Cost $11.05 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	REVANCE THERAPEUTICS INC	3,342,047	$81,613	40.0%	$31.50	—	COM	761330109
—	VENUS CONCEPT, INC.	12,417,856	$43,338	21.3%	$4.17	—	COM	92332W105
—	EYEPOINT PHARMACEUTICALS INC	41,909,219	$31,851	15.6%	$1.64	—	COM	30233G100
AXGN	AXOGEN INC	2,429,999	$22,453	11.0%	$4.01	+123.7%	COM	05463X106
TELA	TELA BIO, INC.	1,391,768	$18,037	8.8%	$12.72	+3.3%	COM	872381108
MNOV	MEDICINOVA INC	1,105,941	$5,994	2.9%	$2.95	+79.8%	COM NEW	58468P206
—	CATALYST BIOSCIENCES INC	78,622	$462	0.2%	$7.36	—	COM NEW	14888D208
—	ENDOLOGIX INC	125,747	$101	0.0%	$11.05	—	COM NEW	29266S304